| Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
| resourceType | ValueSet |
| id | 2.16.840.1.113883.3.88.12.80.22 |
| canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.22 |
| version | 20160602 |
| status | active |
| publisher | HL7 Terminology |
| name | CVXVaccinesAdministeredCompleteSet |
| title | CVX Vaccines Administered Complete Set |
| date | 2016-06-02T01:00:03-04:00 |
| experimental | false |
| description | CVX Vaccine Status is an indication of the current availability of the vaccine for use |
| Usages | (none) |
This value set contains 149 concepts
| Code | System | Display |
| 01 | http://hl7.org/fhir/sid/cvx | diphtheria, tetanus toxoids and pertussis vaccine |
| 02 | http://hl7.org/fhir/sid/cvx | trivalent poliovirus vaccine, live, oral |
| 03 | http://hl7.org/fhir/sid/cvx | measles, mumps and rubella virus vaccine |
| 04 | http://hl7.org/fhir/sid/cvx | measles and rubella virus vaccine |
| 05 | http://hl7.org/fhir/sid/cvx | measles virus vaccine |
| 06 | http://hl7.org/fhir/sid/cvx | rubella virus vaccine |
| 07 | http://hl7.org/fhir/sid/cvx | mumps virus vaccine |
| 08 | http://hl7.org/fhir/sid/cvx | hepatitis B vaccine, pediatric or pediatric/adolescent dosage |
| 09 | http://hl7.org/fhir/sid/cvx | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |
| 10 | http://hl7.org/fhir/sid/cvx | poliovirus vaccine, inactivated |
| 100 | http://hl7.org/fhir/sid/cvx | pneumococcal conjugate vaccine, 7 valent |
| 101 | http://hl7.org/fhir/sid/cvx | typhoid Vi capsular polysaccharide vaccine |
| 102 | http://hl7.org/fhir/sid/cvx | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine |
| 103 | http://hl7.org/fhir/sid/cvx | meningococcal C conjugate vaccine |
| 104 | http://hl7.org/fhir/sid/cvx | hepatitis A and hepatitis B vaccine |
| 105 | http://hl7.org/fhir/sid/cvx | vaccinia (smallpox) vaccine, diluted |
| 106 | http://hl7.org/fhir/sid/cvx | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens |
| 107 | http://hl7.org/fhir/sid/cvx | diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation |
| 108 | http://hl7.org/fhir/sid/cvx | meningococcal ACWY vaccine, unspecified formulation |
| 109 | http://hl7.org/fhir/sid/cvx | pneumococcal vaccine, unspecified formulation |
| 11 | http://hl7.org/fhir/sid/cvx | pertussis vaccine |
| 110 | http://hl7.org/fhir/sid/cvx | DTaP-hepatitis B and poliovirus vaccine |
| 111 | http://hl7.org/fhir/sid/cvx | influenza virus vaccine, live, attenuated, for intranasal use |
| 112 | http://hl7.org/fhir/sid/cvx | tetanus toxoid, unspecified formulation |
| 113 | http://hl7.org/fhir/sid/cvx | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |
| 114 | http://hl7.org/fhir/sid/cvx | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) |
| 115 | http://hl7.org/fhir/sid/cvx | tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed |
| 116 | http://hl7.org/fhir/sid/cvx | rotavirus, live, pentavalent vaccine |
| 118 | http://hl7.org/fhir/sid/cvx | human papilloma virus vaccine, bivalent |
| 119 | http://hl7.org/fhir/sid/cvx | rotavirus, live, monovalent vaccine |
| 12 | http://hl7.org/fhir/sid/cvx | diphtheria antitoxin |
| 120 | http://hl7.org/fhir/sid/cvx | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
| 121 | http://hl7.org/fhir/sid/cvx | zoster vaccine, live |
| 122 | http://hl7.org/fhir/sid/cvx | rotavirus vaccine, unspecified formulation |
| 123 | http://hl7.org/fhir/sid/cvx | influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) |
| 125 | http://hl7.org/fhir/sid/cvx | Novel Influenza-H1N1-09, live virus for nasal administration |
| 126 | http://hl7.org/fhir/sid/cvx | Novel influenza-H1N1-09, preservative-free, injectable |
| 127 | http://hl7.org/fhir/sid/cvx | Novel influenza-H1N1-09, injectable |
| 128 | http://hl7.org/fhir/sid/cvx | Novel influenza-H1N1-09, all formulations |
| 129 | http://hl7.org/fhir/sid/cvx | Japanese Encephalitis vaccine, unspecified formulation |
| 13 | http://hl7.org/fhir/sid/cvx | tetanus immune globulin |
| 130 | http://hl7.org/fhir/sid/cvx | Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated |
| 131 | http://hl7.org/fhir/sid/cvx | Historical record of a typhus vaccination |
| 132 | http://hl7.org/fhir/sid/cvx | Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. |
| 133 | http://hl7.org/fhir/sid/cvx | pneumococcal conjugate vaccine, 13 valent |
| 134 | http://hl7.org/fhir/sid/cvx | Japanese Encephalitis vaccine for intramuscular administration |
| 135 | http://hl7.org/fhir/sid/cvx | influenza, high dose seasonal, preservative-free |
| 136 | http://hl7.org/fhir/sid/cvx | meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) |
| 137 | http://hl7.org/fhir/sid/cvx | HPV, unspecified formulation |
| 138 | http://hl7.org/fhir/sid/cvx | tetanus and diphtheria toxoids, not adsorbed, for adult use |
| 139 | http://hl7.org/fhir/sid/cvx | Td(adult) unspecified formulation |
| 14 | http://hl7.org/fhir/sid/cvx | immune globulin, unspecified formulation |
| 140 | http://hl7.org/fhir/sid/cvx | Influenza, seasonal, injectable, preservative free |
| 141 | http://hl7.org/fhir/sid/cvx | Influenza, seasonal, injectable |
| 142 | http://hl7.org/fhir/sid/cvx | tetanus toxoid, not adsorbed |
| 143 | http://hl7.org/fhir/sid/cvx | Adenovirus, type 4 and type 7, live, oral |
| 144 | http://hl7.org/fhir/sid/cvx | seasonal influenza, intradermal, preservative free |
| 146 | http://hl7.org/fhir/sid/cvx | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. |
| 147 | http://hl7.org/fhir/sid/cvx | Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) |
| 148 | http://hl7.org/fhir/sid/cvx | Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine |
| 149 | http://hl7.org/fhir/sid/cvx | influenza, live, intranasal, quadrivalent |
| 15 | http://hl7.org/fhir/sid/cvx | influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE |
| 150 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, quadrivalent, preservative free |
| 151 | http://hl7.org/fhir/sid/cvx | influenza nasal, unspecified formulation |
| 152 | http://hl7.org/fhir/sid/cvx | Pneumococcal Conjugate, unspecified formulation |
| 153 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, Madin Darby Canine Kidney, preservative free |
| 155 | http://hl7.org/fhir/sid/cvx | Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free |
| 156 | http://hl7.org/fhir/sid/cvx | Rho(D) Immune globulin- IV or IM |
| 157 | http://hl7.org/fhir/sid/cvx | Rho(D) Immune globulin - IM |
| 158 | http://hl7.org/fhir/sid/cvx | influenza, injectable, quadrivalent, contains preservative |
| 159 | http://hl7.org/fhir/sid/cvx | Rho(D) Unspecified formulation |
| 16 | http://hl7.org/fhir/sid/cvx | influenza virus vaccine, whole virus |
| 160 | http://hl7.org/fhir/sid/cvx | Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 |
| 161 | http://hl7.org/fhir/sid/cvx | Influenza, injectable,quadrivalent, preservative free, pediatric |
| 162 | http://hl7.org/fhir/sid/cvx | meningococcal B vaccine, fully recombinant |
| 163 | http://hl7.org/fhir/sid/cvx | meningococcal B vaccine, recombinant, OMV, adjuvanted |
| 164 | http://hl7.org/fhir/sid/cvx | meningococcal B, unspecified formulation |
| 165 | http://hl7.org/fhir/sid/cvx | Human Papillomavirus 9-valent vaccine |
| 166 | http://hl7.org/fhir/sid/cvx | influenza, intradermal, quadrivalent, preservative free, injectable |
| 17 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b vaccine, conjugate unspecified formulation |
| 18 | http://hl7.org/fhir/sid/cvx | rabies vaccine, for intramuscular injection RETIRED CODE |
| 19 | http://hl7.org/fhir/sid/cvx | Bacillus Calmette-Guerin vaccine |
| 20 | http://hl7.org/fhir/sid/cvx | diphtheria, tetanus toxoids and acellular pertussis vaccine |
| 21 | http://hl7.org/fhir/sid/cvx | varicella virus vaccine |
| 22 | http://hl7.org/fhir/sid/cvx | DTP-Haemophilus influenzae type b conjugate vaccine |
| 23 | http://hl7.org/fhir/sid/cvx | plague vaccine |
| 24 | http://hl7.org/fhir/sid/cvx | anthrax vaccine |
| 25 | http://hl7.org/fhir/sid/cvx | typhoid vaccine, live, oral |
| 26 | http://hl7.org/fhir/sid/cvx | cholera vaccine, unspecified formulation |
| 27 | http://hl7.org/fhir/sid/cvx | botulinum antitoxin |
| 28 | http://hl7.org/fhir/sid/cvx | diphtheria and tetanus toxoids, adsorbed for pediatric use |
| 29 | http://hl7.org/fhir/sid/cvx | cytomegalovirus immune globulin, intravenous |
| 30 | http://hl7.org/fhir/sid/cvx | hepatitis B immune globulin |
| 31 | http://hl7.org/fhir/sid/cvx | hepatitis A vaccine, pediatric dosage, unspecified formulation |
| 32 | http://hl7.org/fhir/sid/cvx | meningococcal polysaccharide vaccine (MPSV4) |
| 33 | http://hl7.org/fhir/sid/cvx | pneumococcal polysaccharide vaccine, 23 valent |
| 34 | http://hl7.org/fhir/sid/cvx | rabies immune globulin |
| 35 | http://hl7.org/fhir/sid/cvx | tetanus toxoid, adsorbed |
| 36 | http://hl7.org/fhir/sid/cvx | varicella zoster immune globulin |
| 37 | http://hl7.org/fhir/sid/cvx | yellow fever vaccine |
| 38 | http://hl7.org/fhir/sid/cvx | rubella and mumps virus vaccine |
| 39 | http://hl7.org/fhir/sid/cvx | Japanese Encephalitis Vaccine SC |
| 40 | http://hl7.org/fhir/sid/cvx | rabies vaccine, for intradermal injection |
| 41 | http://hl7.org/fhir/sid/cvx | typhoid vaccine, parenteral, other than acetone-killed, dried |
| 42 | http://hl7.org/fhir/sid/cvx | hepatitis B vaccine, adolescent/high risk infant dosage |
| 43 | http://hl7.org/fhir/sid/cvx | hepatitis B vaccine, adult dosage |
| 44 | http://hl7.org/fhir/sid/cvx | hepatitis B vaccine, dialysis patient dosage |
| 45 | http://hl7.org/fhir/sid/cvx | hepatitis B vaccine, unspecified formulation |
| 46 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b vaccine, PRP-D conjugate |
| 47 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b vaccine, HbOC conjugate |
| 48 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b vaccine, PRP-T conjugate |
| 49 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b vaccine, PRP-OMP conjugate |
| 50 | http://hl7.org/fhir/sid/cvx | DTaP-Haemophilus influenzae type b conjugate vaccine |
| 51 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b conjugate and Hepatitis B vaccine |
| 52 | http://hl7.org/fhir/sid/cvx | hepatitis A vaccine, adult dosage |
| 53 | http://hl7.org/fhir/sid/cvx | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) |
| 54 | http://hl7.org/fhir/sid/cvx | adenovirus vaccine, type 4, live, oral |
| 55 | http://hl7.org/fhir/sid/cvx | adenovirus vaccine, type 7, live, oral |
| 62 | http://hl7.org/fhir/sid/cvx | human papilloma virus vaccine, quadrivalent |
| 66 | http://hl7.org/fhir/sid/cvx | Lyme disease vaccine |
| 69 | http://hl7.org/fhir/sid/cvx | parainfluenza-3 virus vaccine |
| 71 | http://hl7.org/fhir/sid/cvx | respiratory syncytial virus immune globulin, intravenous |
| 74 | http://hl7.org/fhir/sid/cvx | rotavirus, live, tetravalent vaccine |
| 75 | http://hl7.org/fhir/sid/cvx | vaccinia (smallpox) vaccine |
| 76 | http://hl7.org/fhir/sid/cvx | Staphylococcus bacteriophage lysate |
| 77 | http://hl7.org/fhir/sid/cvx | Tick-borne encephalitis vaccine (non-US) |
| 78 | http://hl7.org/fhir/sid/cvx | tularemia vaccine |
| 79 | http://hl7.org/fhir/sid/cvx | vaccinia immune globulin |
| 80 | http://hl7.org/fhir/sid/cvx | Venezuelan equine encephalitis, live, attenuated |
| 801 | http://hl7.org/fhir/sid/cvx | AS03 Adjuvant |
| 81 | http://hl7.org/fhir/sid/cvx | Venezuelan equine encephalitis, inactivated |
| 82 | http://hl7.org/fhir/sid/cvx | adenovirus vaccine, unspecified formulation |
| 83 | http://hl7.org/fhir/sid/cvx | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule |
| 84 | http://hl7.org/fhir/sid/cvx | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule |
| 85 | http://hl7.org/fhir/sid/cvx | hepatitis A vaccine, unspecified formulation |
| 86 | http://hl7.org/fhir/sid/cvx | immune globulin, intramuscular |
| 87 | http://hl7.org/fhir/sid/cvx | immune globulin, intravenous |
| 88 | http://hl7.org/fhir/sid/cvx | influenza virus vaccine, unspecified formulation |
| 89 | http://hl7.org/fhir/sid/cvx | poliovirus vaccine, unspecified formulation |
| 90 | http://hl7.org/fhir/sid/cvx | rabies vaccine, unspecified formulation |
| 91 | http://hl7.org/fhir/sid/cvx | typhoid vaccine, unspecified formulation |
| 92 | http://hl7.org/fhir/sid/cvx | Venezuelan equine encephalitis vaccine, unspecified formulation |
| 93 | http://hl7.org/fhir/sid/cvx | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular |
| 94 | http://hl7.org/fhir/sid/cvx | measles, mumps, rubella, and varicella virus vaccine |
| 95 | http://hl7.org/fhir/sid/cvx | tuberculin skin test; old tuberculin, multipuncture device |
| 96 | http://hl7.org/fhir/sid/cvx | tuberculin skin test; purified protein derivative solution, intradermal |
| 97 | http://hl7.org/fhir/sid/cvx | tuberculin skin test; purified protein derivative, multipuncture device |
| 98 | http://hl7.org/fhir/sid/cvx | tuberculin skin test; unspecified formulation |
| 998 | http://hl7.org/fhir/sid/cvx | no vaccine administered |
Produced 08 Sep 2023